| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA1672299
Max Phase: Preclinical
Molecular Formula: C5H12NO2P
Molecular Weight: 149.13
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: NCC1CCP(=O)(O)C1
Standard InChI: InChI=1S/C5H12NO2P/c6-3-5-1-2-9(7,8)4-5/h5H,1-4,6H2,(H,7,8)
Standard InChI Key: RETRGCNAQIHBAY-UHFFFAOYSA-N
Associated Targets(Human)
GABA-B receptor 281 Activities
GABA-A receptor; alpha-1/beta-2/gamma-2 1171 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
GABA receptor rho-2 subunit 11 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
GABA receptor rho-1 subunit 233 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 149.13 | Molecular Weight (Monoisotopic): 149.0606 | AlogP: 0.24 | #Rotatable Bonds: 1 |
| Polar Surface Area: 63.32 | Molecular Species: ZWITTERION | HBA: 2 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 1.91 | CX Basic pKa: 10.22 | CX LogP: -2.66 | CX LogD: -2.66 |
| Aromatic Rings: 0 | Heavy Atoms: 9 | QED Weighted: 0.52 | Np Likeness Score: 0.46 |
References
| 1. Gavande N, Yamamoto I, Salam NK, Ai TH, Burden PM, Johnston GA, Hanrahan JR, Chebib M.. (2011) Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology., 2 (1): [PMID:24900248] [10.1021/ml1001344] |
Source
Source(1):